We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Stain-Free Imaging Platform Matches Standard Cancer Pathology

By LabMedica International staff writers
Posted on 16 Jun 2026

Histopathology underpins cancer diagnosis, but turnaround times and inter-laboratory variability can limit timely, consistent interpretation. More...

Conventional staining relies on chemical dyes and multiple preparation steps that add time and may affect image quality. A new study shows that a stain-free platform can generate diagnostic images comparable to standard staining while accelerating workflow and supporting algorithm development.

King Abdullah University of Science and Technology (KAUST; Thuwal, Saudi Arabia) has developed a stain-free imaging platform designed to analyze tissue samples more quickly and consistently. The approach replaces dyes with engineered silicon slides that produce detailed structural color images directly from tissue, enabling immediate microscopic assessment. The images are suitable for pathologist review and generate standardized digital data that could support future AI-assisted diagnosis.

The platform was first validated on colorectal tissue, a priority disease area in Saudi Arabia. In a head-to-head evaluation against conventional pathology, the stain-free method achieved 99% agreement in diagnostic conclusions for colorectal specimens. The study assessed tissue from 120 patients and found strong concordance in identifying healthy and cancerous features, while early results indicated a 40–50% reduction in sample preparation time compared with standard workflows.

The research is published in Advanced Science and aligns with KAUST’s Smart Health mission to advance technologies for cancer prevention, diagnosis, and treatment. KAUST is collaborating with King Faisal Specialist Hospital & Research Centre (KFSHRC) Madinah to further evaluate the platform across broader healthcare settings in Saudi Arabia. 

In addition to colorectal samples, tests on breast, lung, and thyroid tissues captured key histological features comparable to conventionally stained slides, supporting additional validation efforts. The team states the system was developed with practical deployment in mind and will continue to be assessed for clinical and commercial pathways.

“This research focuses on improving one of the most important steps in diagnosis: how tissue samples are prepared and reviewed,” said Qiaoqiang Gan, Professor of Material Science and Engineering at KAUST. “Traditional staining methods can be influenced by preparation steps, reagent quality, and laboratory conditions. By generating consistent digital images without dyes, we can reduce variability and create data that is more reliable for both clinical review and future AI-assisted analysis.”

Related Links
KAUST


New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Online QC Software
Acusera 24•7
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.